Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-061792
Filing Date
2025-06-23
Accepted
2025-06-23 18:24:40
Documents
2
Period of Report
2025-06-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2518376-5_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2518376-5_3seq1.xml 3 4829
2 EXHIBIT 24 tm2518376d5_ex24.htm EX-24 6630
  Complete submission text file 0001104659-25-061792.txt   12923
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TETRAPHASE PHARMACEUTICALS, INC. 480 ARSENAL STREET, SUITE 110 WATERTOWN MA 02472
Business Address
Lubner David Charles (Reporting) CIK: 0001572000 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36177 | Film No.: 251066192